반응식
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH3:19])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=O)[C:6]=2[CH:22]=1.COC1C=CC(P2(=S)SP(=S)(C3C=CC(OC)=CC=3)[S:32]2)=CC=1>C1(C)C=CC=CC=1>[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18][CH3:19])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[S:32])[C:6]=2[CH:22]=1참가 물질
실험 절차
10.7 g (35.3 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate and 7.13 g (17.6 mmol) of 2,4-bis(p-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulphide in 100 ml of toluene are heated to boiling under reflux for 22 hours. The mixture is subsequently concentrated in vacuo until crystallisation begins and is then left to stand in an ice-bath for 1 hour. The crystallised-out material is filtered off under suction and washed with a small amount of toluene. The mixture is separated on silica gel with ethyl acetate/chloroform (1:9). After recrystallisation from ethyl acetate, there is obtained pure ethyl 8-fluoro-5,6-dihydro-5-methyl-6-thioxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 157°-159° C.
후처리
- temperatureunder reflux for 22 hours
- concentrationThe mixture is subsequently concentrated in vacuo until crystallisation
- waitis then left
- filtrationThe crystallised-out material is filtered off under suction
- washwashed with a small amount of toluene
- customThe mixture is separated on silica gel with ethyl acetate/chloroform (1:9)
- customAfter recrystallisation from ethyl acetate
출처 및 근거
- ORD 기록
- ord-b84ca8c0e2f343cc8dfa43723674dc70
- 출처 데이터셋
- uspto-grants-1982_08
- 특허 번호
- US04346030
연결된 노트
불러오는 중…